Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Join Barchart Premier to get Screeners that run automatically with the results emailed to you! FREE 30 Day Trial
Stocks | Futures | Watchlist | More
or

Cronos Group Inc (CRON)

Cronos Group Inc (CRON)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 920,647
  • Shares Outstanding, K 382,011
  • Annual Sales, $ 87,240 K
  • Annual Income, $ -73,960 K
  • 60-Month Beta 1.17
  • Price/Sales 10.60
  • Price/Cash Flow N/A
  • Price/Book 0.85
Trade CRON with:

Options Overview Details

View History
  • Implied Volatility 60.32% ( +1.23%)
  • Historical Volatility 55.34%
  • IV Percentile 43%
  • IV Rank 50.15%
  • IV High 92.90% on 08/31/23
  • IV Low 27.54% on 10/19/23
  • Put/Call Vol Ratio 0.92
  • Today's Volume 1,277
  • Volume Avg (30-Day) 11,972
  • Put/Call OI Ratio 0.60
  • Today's Open Interest 283,679
  • Open Int (30-Day) 217,903

Analyst Rating / Earnings Estimates

Current Rating
See More
Moderate Buy
Based on 7 analysts offering recommendations.
Earnings Estimates - Current Qtr 03/31/24
See More
  • Average Estimate -0.01
  • Number of Estimates 3
  • High Estimate 0.00
  • Low Estimate -0.01
  • Prior Year -0.03
  • Growth Rate Est. (year over year) +66.67%

Price Performance

See More
Period Period Low Period High Performance
1-Month
2.28 +3.96%
on 03/20/24
2.99 -20.74%
on 04/04/24
+0.08 (+3.49%)
since 03/19/24
3-Month
1.89 +25.40%
on 03/05/24
2.99 -20.74%
on 04/04/24
+0.37 (+18.50%)
since 01/19/24
52-Week
1.64 +44.51%
on 08/08/23
2.99 -20.74%
on 04/04/24
+0.43 (+22.16%)
since 04/19/23

Most Recent Stories

More News
Why Marijuana Stocks Got Burnt Today

If even Tilray can't make money from marijuana, what hope does any company have?

TLRY : 1.7300 (+0.58%)
CRON : 2.37 (-1.66%)
CGC : 7.93 (+1.28%)
ACB : 6.46 (-1.15%)
Why Canopy Growth, Cronos, and Aurora Cannabis Stocks Popped on Monday

What is the safest way to bet on SAFER marijuana banking reform?

CGC : 7.93 (+1.28%)
CRON : 2.37 (-1.66%)
ACB : 6.46 (-1.15%)
Why Canadian Marijuana Stocks Popped Today

Several developments pushed north-of-our-border weed titles higher on the day.

CGC : 7.93 (+1.28%)
TLRY : 1.7300 (+0.58%)
SNDL : 1.8700 (+2.19%)
CRON : 2.37 (-1.66%)
Why Marijuana Stocks Are Hopping Again on Tuesday

Three out of five voters surveyed would like marijuana to be cheaper.

CRON : 2.37 (-1.66%)
SNDL : 1.8700 (+2.19%)
CGC : 7.93 (+1.28%)
Why Tilray, Cronos, and Canopy Growth Stocks All Popped Today

Two of these three cannabis stocks will benefit most from today's marijuana news.

CRON : 2.37 (-1.66%)
TLRY : 1.7300 (+0.58%)
CGC : 7.93 (+1.28%)
1 High-Yield Dividend King to Scoop Up While It's Cheap

Amidst a volatile market, Altria Group is a standout Dividend King that's committed to rewarding shareholders - and the company's freshly raised fiscal 2024 earnings guidance is just one reason to consider...

^BTCUSD : 63,800.14 (-0.30%)
CLJ24 : 81.68s (-2.14%)
GCJ24 : 2,398.4s (+0.68%)
MO : 42.09 (+1.91%)
CRON : 2.37 (-1.66%)
BUD : 58.74 (+1.43%)
$SPX : 4,967.23 (-0.88%)
Cronos Group (CRON) Q4 2023 Earnings Call Transcript

CRON earnings call for the period ending December 31, 2023.

CRON : 2.37 (-1.66%)
Is It Too Late to Buy Altria Stock?

The tobacco company could be running on fumes.

MO : 42.09 (+1.91%)
PM : 93.77 (+2.82%)
CRON : 2.37 (-1.66%)
Hemp-CBD Market Demand Gaining Momentum While Projected to Reach $16 Billion By 2025

EQNX::TICKER_START (OTCQB:PBIO),(NASDAQ:CGC),(NASDAQ:TLRY),(NASDAQ:CRON),(OTCQX:CWBHF) EQNX::TICKER_END

PBIO : 0.2560 (-5.08%)
CGC : 7.93 (+1.28%)
TLRY : 1.7300 (+0.58%)
CRON : 2.37 (-1.66%)
CWBHF : 0.2198 (+4.22%)
Hemp-CBD Market Demand Gaining Momentum While Projected to Reach $16 Billion By 2025

PBIO : 0.2560 (-5.08%)
CGC : 7.93 (+1.28%)
TLRY : 1.7300 (+0.58%)
CRON : 2.37 (-1.66%)
CWBHF : 0.2198 (+4.22%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 88% Buy with a Weakening short term outlook on maintaining the current direction.

Long term indicators fully support a continuation of the trend.

See More Share

Business Summary

Cronos Group, Inc. engages in the investment in firms which are licensed to produce and sell medical marijuana. Its portfolio includes In The Zone, Peace Naturals, Whistler Medical Marijuana Co., ABcann, Hydropothecary, Vert Medical and Evergreen Medicinal Supply. Cronos Group Inc., formerly known as...

See More

Key Turning Points

3rd Resistance Point 2.54
2nd Resistance Point 2.50
1st Resistance Point 2.43
Last Price 2.37
1st Support Level 2.32
2nd Support Level 2.28
3rd Support Level 2.21

See More

52-Week High 2.99
Fibonacci 61.8% 2.47
Last Price 2.37
Fibonacci 50% 2.32
Fibonacci 38.2% 2.16
52-Week Low 1.64

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar